NATALIE INABNETT: Open Payments
NPI 1598148744 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 79 payments from 14 companies in 2025. Trend: 2023 $560 · 2024 $962 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 25 | $302 |
| ABBVIE INC. | 23 | $228 |
| Janssen Biotech, Inc. | 11 | $166 |
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 5 | $96 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| Aimmune Therapeutics, Inc. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Madrigal Pharmaceuticals | 2 | $36 |
| GENZYME CORPORATION | 1 | $29 |
Products named: IBSRELA, TREMFYA, Wegovy, CREON, VOQUEZNA, LINZESS, IQIRVO, ZENPEP.
Industry payments across SC — which companies pay providers there.
